Literature DB >> 21742211

ARDS Network (NHLBI) studies: successes and challenges in ARDS clinical research.

B Taylor Thompson1, Gordon R Bernard.   

Abstract

To hasten the development of effective therapy for acute respiratory distress syndrome (ARDS), in 1994, the National Heart, Lung, and Blood Institute initiated a clinical network to carry out multicenter clinical trials of ARDS treatments. The ARDS Network is a clinical research network of approximately 42 hospitals, organized into 12 clinical sites. The goal of the Network is to efficiently test promising agents, devices, or management strategies to improve the care of patients with ARDS. Comprehensive information regarding all completed and ongoing ARDSNet clinical trials is available at www.ardsnet.org, but a brief summary is provided in this article.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742211      PMCID: PMC3143063          DOI: 10.1016/j.ccc.2011.05.011

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  10 in total

1.  Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

Authors:  Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; David Schoenfeld; Herbert P Wiedemann; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

3.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Authors:  Kenneth P Steinberg; Leonard D Hudson; Richard B Goodman; Catherine Lee Hough; Paul N Lanken; Robert Hyzy; B Taylor Thompson; Marek Ancukiewicz
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

4.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

Authors:  M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

5.  Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.

Authors: 
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

6.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

7.  Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 8.  Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement.

Authors:  G R Bernard; G Sopko; F Cerra; R Demling; H Edmunds; S Kaplan; L Kessler; H Masur; P Parsons; D Shure; C Webb; H Weidemann; G Weinmann; D Williams
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

9.  Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

Authors:  Roy G Brower; Paul N Lanken; Neil MacIntyre; Michael A Matthay; Alan Morris; Marek Ancukiewicz; David Schoenfeld; B Taylor Thompson
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

10.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators.

Authors:  A F Connors; T Speroff; N V Dawson; C Thomas; F E Harrell; D Wagner; N Desbiens; L Goldman; A W Wu; R M Califf; W J Fulkerson; H Vidaillet; S Broste; P Bellamy; J Lynn; W A Knaus
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

  10 in total
  17 in total

1.  TAT-HSP70 Attenuates Experimental Lung Injury.

Authors:  M Melanie Lyons; Nichelle N Raj; Jesse L Chittams; Laurie Kilpatrick; Clifford S Deutschman
Journal:  Shock       Date:  2015-06       Impact factor: 3.454

2.  Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.

Authors:  Anna Zuk; Paul M Palevsky; Linda Fried; Frank E Harrell; Samina Khan; Dianne B McKay; Luke Devey; Lakhmir Chawla; Mark de Caestecker; James S Kaufman; B Taylor Thompson; Anupam Agarwal; Tom Greene; Mark Douglas Okusa; Joseph V Bonventre; Laura M Dember; Kathleen D Liu; Benjamin D Humphreys; Daniel Gossett; Yining Xie; Jenna M Norton; Paul L Kimmel; Robert A Star
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-09       Impact factor: 8.237

3.  Construction and management of ARDS/sepsis registry with REDCap.

Authors:  Xiaoqing Pang; Natascha Kozlowski; Sulong Wu; Mei Jiang; Yongbo Huang; Pu Mao; Xiaoqing Liu; Weiqun He; Chaoyi Huang; Yimin Li; Haibo Zhang
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

4.  Up-regulation of SFTPB expression and attenuation of acute lung injury by pulmonary epithelial cell-specific NAMPT knockdown.

Authors:  Guangliang Bi; Lei Wu; Peixin Huang; Shamima Islam; Daniel P Heruth; Li Qin Zhang; Ding-You Li; Venkatesh Sampath; Weimin Huang; Brett A Simon; Ronald Blaine Easley; Shui Qing Ye
Journal:  FASEB J       Date:  2018-02-08       Impact factor: 5.191

5.  Injury Characteristics and von Willebrand Factor for the Prediction of Acute Respiratory Distress Syndrome in Patients With Burn Injury: Development and Internal Validation.

Authors:  Majid Afshar; Ellen L Burnham; Cara Joyce; Robin Gagnon; Robert Dunn; Joslyn M Albright; Luis Ramirez; John E Repine; Giora Netzer; Elizabeth J Kovacs
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

Review 6.  Molecular pathology of emerging coronavirus infections.

Authors:  Lisa E Gralinski; Ralph S Baric
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

7.  Elevated positive end-expiratory pressure decreases cardiac index in a rhesus monkey model.

Authors:  Patrick A Ross; Robinder G Khemani; Sarah S Rubin; Anoopindar K Bhalla; Christopher J L Newth
Journal:  Front Pediatr       Date:  2014-12-03       Impact factor: 3.418

8.  Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death.

Authors:  Pavan K Bhatraju; Paramita Mukherjee; Cassianne Robinson-Cohen; Grant E O'Keefe; Angela J Frank; Jason D Christie; Nuala J Meyer; Kathleen D Liu; Michael A Matthay; Carolyn S Calfee; David C Christiani; Jonathan Himmelfarb; Mark M Wurfel
Journal:  Crit Care       Date:  2016-11-17       Impact factor: 9.097

Review 9.  Acute Respiratory Distress Syndrome.

Authors:  George W Williams; Nathaniel K Berg; Alexander Reskallah; Xiaoyi Yuan; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2021-02-01       Impact factor: 7.892

10.  High Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-Like Transcript (TLT)-1 Are Associated With Acute Respiratory Distress Syndrome.

Authors:  Jessica Morales-Ortíz; Matthew T Rondina; Samuel M Brown; Colin Grissom; A Valance Washington
Journal:  Clin Appl Thromb Hemost       Date:  2018-05-14       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.